Effects of Withania somnifera in patients of schizophrenia: a randomized, double blind, placebo controlled pilot trial study. – Cost Effective Supplements

Effects of Withania somnifera in patients of schizophrenia: a randomized, double blind, placebo controlled pilot trial study.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/24014929

Conclusion of this study

A statistically significant (P<0.05) reduction in serum triglycerides and FBG was observed after 1 month of WS treatment compared to the placebo group. Patients of both groups reported feeling of isolation and depression.